584 related articles for article (PubMed ID: 15218318)
1. Abuse of recombinant human growth hormone: studies in two different dog models.
Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
[TBL] [Abstract][Full Text] [Related]
2. Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog.
Rigamonti AE; Cella SG; Giordani C; Bonomo SM; Giunta M; Sartorio A; Muller E
Neuroendocrinology; 2006; 84(2):115-22. PubMed ID: 17106185
[TBL] [Abstract][Full Text] [Related]
3. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
Rigamonti AE; Bonomo SM; Cella SG; Müller EE
J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
Rigamonti AE; Cavallera G; Bonomo S; Deghenghi R; Locatelli V; Cella SG; Müller EE
Eur J Endocrinol; 2001 Nov; 145(5):635-44. PubMed ID: 11720883
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
[TBL] [Abstract][Full Text] [Related]
6. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
[TBL] [Abstract][Full Text] [Related]
7. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
Leal-Cerro A; Soto A; Martínez MA; Alvarez P; Isidro L; Casanueva FF; Dieguez C; Cordido F
Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.
DeBell WK; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1991 Jun; 72(6):1312-6. PubMed ID: 2026752
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity.
Pincelli AI; Rigamonti AE; Scacchi M; Cella SG; Cappa M; Cavagnini F; Müller EE
Eur J Endocrinol; 2003 Feb; 148(2):237-43. PubMed ID: 12590644
[TBL] [Abstract][Full Text] [Related]
11. Growth Hormone (GH) but not IGF-I-Secretion is Stimulated in Aged Rats by Chronic Hexarelin and GHRP-6 administration.
Settembrini B; Figueroa J; Gallardo M; Chiocchio S
Endocr Regul; 1998 Mar; 32(1):17-26. PubMed ID: 10407366
[TBL] [Abstract][Full Text] [Related]
12. E2 supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion.
Anderson SM; Wideman L; Patrie JT; Weltman A; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Dec; 86(12):5904-11. PubMed ID: 11739462
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic/pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeys.
Sun YN; Lee HJ; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1523-32. PubMed ID: 10336548
[TBL] [Abstract][Full Text] [Related]
14. Involvement of nitric oxide in the regulation of growth hormone secretion in dogs.
Valverde I; Peñalva A; Ghigo E; Casanueva FF; Dieguez C
Neuroendocrinology; 2001 Oct; 74(4):213-9. PubMed ID: 11598377
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
Bowers CY; Granda-Ayala R
Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
[TBL] [Abstract][Full Text] [Related]
16. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
[TBL] [Abstract][Full Text] [Related]
17. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
Anderson SM; Shah N; Evans WS; Patrie JT; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model.
Weekers F; Van Herck E; Isgaard J; Van den Berghe G
Endocrinology; 2000 Nov; 141(11):3993-9. PubMed ID: 11089529
[TBL] [Abstract][Full Text] [Related]
19. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
Rigamonti AE; Marazzi N; Cella SG; Cattaneo L; Müller EE
J Endocrinol; 1998 Feb; 156(2):341-8. PubMed ID: 9518881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
